Report Highlights Need for Stakeholder Driven Evidence Generation Strategy and Pricing-Value Assessment for Market Access Success
Bethesda, Maryland (PRWEB) February 08, 2013
Novel Health Strategies team analyzed marketing, pricing, access and launch strategies for all products approved in 2011-2012 to develop a report on top strategy mishaps. The goal of this report is to provide industry executives with an analysis of mistakes made by manufacturers for launching recent products and develop lessons and implications for 2013-2020. This report was developed by Novel Health Strategies team in partnership with key opinion leaders and market access stakeholders.
The following topics are discussed in the report:
What were the top mistakes made by manufacturers for products launched in 2011-2012?
What factors led to the failure of products, previously deemed as potential blockbusters?
How did KOLs and payer stakeholders react to manufacturer's strategies?
What lessons can be learned from recent product launch failures for future products?
What market access and evidence generation strategies can be developed for future products?
The report is complementary and can be requested for in-person presentation by emailing at firstname.lastname@example.org
About Novel Health Strategies LLC
Novel Health Strategies LLC ("Novel Health") is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives. Novel Health has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings.